Signifikante Kardiotoxizität von Trastuzumab bei der adjuvanten Systemtherapie älterer Patientinnen mit Mammakarzinom
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology Nuclear Medicine and imaging
Link
http://link.springer.com/content/pdf/10.1007/s00066-014-0683-4.pdf
Reference7 articles.
1. Chavez-MacGregor M, Zhang N, Buchholz TA et al (2013) Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol 31:4222–4228 (=Originalbeitrag")
2. Halyard MY, Pisansky TM, Dueck AC et al (2009) Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. J Clin Oncol 27:2638–2644
3. Erven K, Florian A, Slagmolen P et al (2013) Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys 85:1172–1178
4. Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998
5. Petersen C, Würschmidt F (2011) Late toxicity of radiotherapy: a problem or a challenge for the radiation oncologist? Breast Care (Basel) 6:369–374
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Retrospective Comparison of Trastuzumab Plus Cisplatin and Trastuzumab Plus Capecitabine in Elderly HER2-Positive Advanced Gastric Cancer Patients;Medicine;2015-08
2. DEGRO practical guidelines for radiotherapy of breast cancer V;Strahlentherapie und Onkologie;2015-05-12
3. Trastuzumab ist signifikant kardiotoxisch;Info Onkologie;2014-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3